TechFlow news — On November 8, according to The Block, Binance Labs announced its first move into decentralized science (DeSci) by investing an undisclosed amount in BIO Protocol. BIO Protocol aims to transform early-stage scientific research funding and commercialization models using blockchain technology. Binance Labs likened it to a "Y Combinator for on-chain science."
The platform enables global scientists, patients, and investors to collectively fund, develop, and own new medicines through biotech DAOs, with a special focus on areas traditionally underserved by research funding—such as rare diseases, longevity, and emerging health challenges. Currently, the BIO ecosystem includes seven "BioDAOs" dedicated to research projects including cryopreservation, women's health, and psychedelics for mental health. The next wave of projects will address long COVID and rare disease treatments, as well as the development of quantum microscopes for observing quantum biological phenomena.
![In-depth Analysis of Trade[XYZ]: How Were 92 Markets and 98% HIP-3 Trading Volume Established?](https://upload.techflowpost.com/upload/images/20260716/20260716061117965147.jpeg?x-oss-process=image/resize,p_50/quality,q_80)
